EQT Life Sciences — Full Portfolio

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.

BiotechHealthtechMedical Devices

DMDr. Mark Throsby(Chief Executive Officer)

Co-investorsMRMRL Ventures FundV-V-Bio VenturesVIVIVES PartnersSASambrinvestWAWallonie Entreprendre

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

RFRobert Friesen(Founder)in

Co-investorsBIBioGeneration VenturesBOBOMCUCurie CapitalKUKurma PartnersV-V-Bio Ventures

Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.

Biotech

Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in

BoardMDMichel Detheux(Chairman)in

Co-investorsFUFund+JDJDRF T1D Fund

ViCentra develops Kaleido, a compact and user-friendly insulin pump system for people with Type 1 diabetes.

Digital HealthHardwareMedical DevicesUtrecht, DE

Tim Oakes(CTO and Co-founder)

Co-investorsINInnovation IndustriesINInkef

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

RHRoger Heerman(Chief Business/Operating Officer / Co-Founder)inFMFrazer Morgan(Chief Development Officer / Co-Founder)inRCRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJBJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5A5AM VenturesATAtlas VentureRARA CapitalSISixty Degree CapitalVIVivo CapitalGIGimv+3 more

MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.

BiotechHealthtech

PerBengt(CSO)

Co-investorsADAdjuvant CapitalINIndustrifondenOROrbiMedPUPureos BioventuresSASanofi VenturesSUSunstone Capital+2 more

Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.

BiotechHealthtechMedical DevicesGhent, BE

Co-investorsNENewton BiocapitalBLBlackRockKRKreos CapitalRORosetta Capital Ltd.VIVI PartnersBOBootstrap Europe+2 more

T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.

BiotechHealthtechBerlin, DE

EKElisa Kieback(Co-founder & Chief Technology Officer)inTBThomas Blankenstein(Scientific Founder)TSThomas Soloway(Chief Executive Officer)CLCamille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in

Co-investorsANAndera PartnersVEVersant VenturesRARA CapitalSISixty Degree CapitalFIFidelity Investments

VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.

BiotechHealthtechMedical Devices

Pieter ReitsmainJGJohn Glasspool(Chief Executive Officer)in

Co-investorsSOSound BioventuresYSYsios CapitalBIBioGeneration VenturesEIEICINInkefUNUNIIQ+2 more

Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

LDLuc Dochez(Chair and Founder)inJMJosh Mandel-Brehm(Co-Founder)in

Co-investorsDRDroia VenturesKUKurma PartnersPUPureos BioventuresSESeroba Life SciencesEUEurazeoIDIdinvest Partners+1 more

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

LPLuis Pena(Executive Officer, Director)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Board seatFVFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025

Co-investorsANAndera PartnersAVAvego BioScience CapitalB B Capital GroupB4B4 CapitalBEBeiersdorf Innovation FundFEFemHealth Ventures+3 more

Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechBoston, US

RHRobbie Hughes(CEO and Founder)in

Board seatRDRudy Dekeyser· per SEC Form D · $12M raise · filed Aug 2023

Co-investorsENEndeavour VisionOPOptum VenturesTETechstarsAMAmadeus Capital Partners

1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.

AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US

BØBernt Øyvind Børnich(CEO)inBBBernt Børnich(Founder)in

Co-investorsACAccess Ventures (New York)ALAlliance VCALAlliance VentureEQEQT VenturesSASamsung NextSASandwater+9 more

Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.

BiotechDeep TechHealthtechMedical Devices

SMStuart Milstein(Co-Founder)inJOJack O’Meara(Cofounder)in

Co-investorsAGage1BABackedBLBlueYard CapitalENEntrepreneur FirstIAIaso VenturesPSPsyMed Ventures+4 more

Co-investorsANAndera PartnersCTCTI Life Sciences Fund L.P.KUKurma PartnersLSLSP (Life Sciences Partners)SOSofinnova Partners

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.

BiotechHealthtechMedical Devices

Co-investorsANAndera PartnersM M VenturesNONovartis Venture FundPFPfizer Venture InvestmentsRARA CapitalSOSofinnova Partners+2 more

Biotech

Co-investorsKUKurma PartnersSOSofinnova PartnersJOJohnson & Johnson Innovation – JJDCM M VenturesSRSR One Capital Management

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsF-F-Prime CapitalNONovartis Venture FundRIRiverVest Venture PartnersSASanofi VenturesABabrdn plc

Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, US

Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.

BiotechDeep TechMedical DevicesNiel, BE

Co-investorsFUFund+PMPMVBOBoehringer Ingelheim Venture FundNONovalis LifeSciencesPWPWV

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.

HealthtechMedical Devices

Co-investorsATAtlantic Bridge VenturesCLClaret Capital PartnersMVMVM Life Science PartnersENEnterprise IrelandFOFountain Healthcare PartnersSOSofinnova Partners+1 more

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)JJJon J. Snyder(Director, President, Secretary and CEO)in

BoardJEJoyce Erony(Director)inWilliam Harrington(Director)

Co-investorsAMAmzak HealthAPAPERTURE Venture PartnersCWCWRU Technology VenturesISiSelect FundJOJobsOhio VenturesJUJumpstart Ventures+6 more

NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.

BiotechHealthtechMedical Devices

Co-investorsBABain Capital Life SciencesFRFrazier Life SciencesLSLSP (Life Sciences Partners)FOForbion

Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.

AI & Machine LearningHealthtechIoT

RPRoeland Pelgrims(Founder)in

Co-investors1515th RockANAngelini VenturesPMPMV

Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.

BiotechHealthtechMedical Devices

ILIlise Lombardo(Chief Executive Officer)inVKVolker Knappertz(Executive Vice President of Research & Development)inMSMichael Samar(Chief Financial Officer)inRLRob Lasser(Chief Medical Officer)in

Co-investorsBIBioMedPartnersJEJeito CapitalRORoche Venture FundSOSofinnova PartnersEQEQTFOForbion+2 more

NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.

FemTechHealthtechMedical DevicesGalway, IE

Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)

Co-investorsTMTMC Venture FundENEnterprise Ireland

Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.

Digital HealthHealthtechMedical DevicesEindhoven, NL

Co-investors1515th RockLSLSP (Life Sciences Partners)IMimec.xpandINInnovation Industries

PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.

BiotechDeep TechHealthtechMedical DevicesMol, BE

SVSven van den berghe(CEO)inCMChristophe Malice(CBO)inSamy Bertrand(CTO)inYSYves Sterckx(Director of Finance & Administration)inPhilippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)

Co-investorsKOKorysKUKurma PartnersLSLSP (Life Sciences Partners)PMPMV

Payrails provides a modular financial operating system for enterprises that manages payment and financial workflows.

Enterprise SoftwareFintechSaaSBerlin, DE

ETEmre Talay(Founder)inNicolas Thouzeau(Founder)inOAOrkhan Abdullayev(Founder)in

Co-investorsANAndreessen HorowitzDEDeBa VenturesEQEQT VenturesGEGeneral CatalystHVHV Capital

Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.

Deep TechHealthtechMedical DevicesGalway City, IE

WAWayne Allen(Co-Founder, CEO, Director)inLMLiam Mullins(CTO and Co-founder)in

Co-investorsSESeroba Life SciencesSVSV Health InvestorsENEnterprise Ireland

Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.

Deep TechDigital HealthHealthtechMedical Devices

Co-investorsAPAphelion CapitalINInnvotec Ltd.NONorthern GritstoneSESectoral Asset Management

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

KEKevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)KRKasper Roet(Director, Executive Officer, Promoter)inSVShafique Virani(Executive Officer)inJBJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsDRDroia VenturesMCMC Healthcare VenturesMIMission BiocapitalMIMitsui Global InvestmentSASanofi VenturesSVSV Health Investors+7 more

RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.

BiotechHealthtech

Co-investorsFRFrazier Life SciencesLILifeArc VenturesFOForbionOXOxford Science EnterprisesRERed Tree VentureWEWellington Management

Sana is an AI lab that develops agentic AI systems to help teams access knowledge, automate repetitive work, and learn.

AI & Machine LearningEnterprise SoftwareFuture of WorkStockholm, SE

Co-investorsACAcequia Capital (AceCap)EQEQT VenturesLELeksell Social VenturesMEMenlo VenturesNENew Enterprise Associates (NEA)WOWorkday Ventures

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsASAstellas Venture Management LLCF-F-Prime CapitalFAFast Track InitiativeJIJIC Venture Growth InvestmentsKYKyoto University Innovation Capital

SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.

BiotechDeep TechDigital HealthBarcelona, ES

DVDr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)

Co-investorsNONovartis Venture FundRORoche Venture FundSASanofi VenturesYSYsios CapitalASAsabys PartnersCRCriteria Bio Ventures+3 more

Vaderis develops a first-of-its-kind oral therapy for hereditary hemorrhagic telangiectasia (HHT), a rare vascular disease with no existing approved treatments.

BiotechHealthtechMedical Devices

Co-investorsDRDroia VenturesMEMedicxiGOGoldman Sachs

VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.

AI & Machine LearningData & InfrastructureFintech

Co-investorsAIAIN VenturesMUMultiball CapitalDRDroia VenturesEUEurazeoKUKurma PartnersPUPureos Bioventures

The World Health Organization is a United Nations agency founded in 1948 that leads global health initiatives and emergency response across 194 member states.

Digital HealthGovTechHealthtech

Co-investorsATatai Life SciencesATAtaiBeckleyICICONIQMAMaRS

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.

BiotechDeep TechHealthtechMedical Devices

ESEliane Schutte(Chief Executive Officer)in

Co-investorsKUKurma PartnersVIVI PartnersYSYsios CapitalAMAmadeus Capital PartnersINInvest-NL